SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-026089
Filing Date
2021-05-10
Accepted
2021-05-10 16:33:30
Documents
65
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q aveo-10q_20210331.htm   iXBRL 10-Q 2698988
2 EX-10.2 aveo-ex102_64.htm EX-10.2 844426
3 EX-10.3 aveo-ex103_63.htm EX-10.3 26065
4 EX-31.1 aveo-ex311_6.htm EX-31.1 16530
5 EX-31.2 aveo-ex312_9.htm EX-31.2 16525
6 EX-32.1 aveo-ex321_7.htm EX-32.1 4468
7 EX-32.2 aveo-ex322_8.htm EX-32.2 4459
  Complete submission text file 0001564590-21-026089.txt   11560694

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA aveo-20210331.xsd EX-101.SCH 67616
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aveo-20210331_cal.xml EX-101.CAL 47212
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aveo-20210331_def.xml EX-101.DEF 256745
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE aveo-20210331_lab.xml EX-101.LAB 523134
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aveo-20210331_pre.xml EX-101.PRE 401696
13 EXTRACTED XBRL INSTANCE DOCUMENT aveo-10q_20210331_htm.xml XML 2179281
Mailing Address 30 WINTER STREET BOSTON MA 02108
Business Address 30 WINTER STREET BOSTON MA 02108 857-400-0101
AVEO PHARMACEUTICALS, INC. (Filer) CIK: 0001325879 (see all company filings)

IRS No.: 043581650 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34655 | Film No.: 21907762
SIC: 2834 Pharmaceutical Preparations